Skip to main content
Log in

The preliminary study on HMBA-induced differentiation of the drug-pretreated murine erythroleukemia cells

  • Basic Investigations
  • Published:
Chinese Journal of Cancer Research

Abstract

Several drug-resistant variants have been developed by growing the parental MEL cells in presence of colchicine, adriamycin and vincristine respectively with stepwise increasing concentration. Both the colchicine-resistant Sc9(Co10) and vincristine-resistant Sc9(VCR5) cells displayed an accelerated HMBA-induced commitment to terminal cell differentiation, whereas the adriamycin-resistant SC9 (A120) showed no acceleration but rather a substantial delay in HMBA-induced differentiation. The studies provide more clues as well as experimental models for further study on the mechanism of induced differentiation of MEL cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Melloni E, et al. Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylene bisacetamide-induced differentiation. Proc Natl Acad Sci USA 1988; 85:3835.

    Article  PubMed  CAS  Google Scholar 

  2. Michaeli J, et al. Differentiation-resistant murine erythroleukemia cells become highly inducible following selection for vincristine resistance. Subfitted for publication.

  3. Fibach E, et al. Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation. Cancer Res 1987; 38:3685.

    Google Scholar 

  4. Fibach E, et al. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells. Cancer Res 1977; 37:440.

    PubMed  CAS  Google Scholar 

  5. Chen ZX, et al. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: A multistep process. Proc Natl Acad Sci USA 1982; 79:471.

    Article  PubMed  CAS  Google Scholar 

  6. Shen DW, et al. Human multidrug-resistant cell lines: Increased mdr expression can precede gene amplification. Science 1986; 232:643.

    Article  PubMed  CAS  Google Scholar 

  7. Van der Bliek AM, et al. Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res 1988; 48:5972.

    Google Scholar 

  8. Fojo A, et al. Reduced drug accumulation in multiple drug resistant human KB carcinoma cell lines. Cancer Res 1985; 45:3002.

    PubMed  CAS  Google Scholar 

  9. Lemontt JF, et al. Increased mdr gene expression and decreased drug accumulation in multidrug-resistant human melanoma cells. Cancer Res 1988; 48:6348.

    PubMed  CAS  Google Scholar 

  10. Bellamy WT, et al. Verapamil reversal of donorubicin resistance in multidrug-resistant human melanoma cells and association with drug accumulation and DNA damage. Cancer Res 1988; 48:6303.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Z., Michaeli, J., Marks, P. et al. The preliminary study on HMBA-induced differentiation of the drug-pretreated murine erythroleukemia cells. Chinese Journal of Cancer Research 1, 24–28 (1989). https://doi.org/10.1007/BF02684813

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02684813

Keywords

Navigation